Acute rhabdomyolysis caused by combination therapy with atorvastatin and warfarin

被引：13

作者：

MacKay, J. W. ^{[1
]}

Fenech, M. E. ^{[1
]}

Myint, K. S. ^{[1
]}

机构：

[1] Norfolk & Norwich Univ Hosp, Elsie Bertram Diabet Ctr, Norwich NR4 7UY, Norfolk, England

来源：

BRITISH JOURNAL OF HOSPITAL MEDICINE | 2012年 / 73卷 / 02期

关键词：

D O I：

10.12968/hmed.2012.73.2.106

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：106 / 107

页数：2

共 8 条

[1] Oral anticoagulant drug interactions with statins: Case report of fluvastatin and review of the literature [J].

Andrus, MR .

PHARMACOTHERAPY, 2004, 24 (02) :285-290

[2]

Iliadis E A, 1995, Pa Med, V98, P31

[3] The effect of converting from pravastatin to simvastatin on the pharmacodynamics of warfarin [J].

Lin, JC ;

Ito, MK ;

Stolley, SN ;

Morreale, AP ;

Marcus, DB .

JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (01) :86-90

[4] Rhabdomyolysis and acute renal failure due to combination therapy with simvastatin and warfarin [J].

Mogyorósi, A ;

Bradley, B ;

Showalter, A ;

Schubert, ML .

JOURNAL OF INTERNAL MEDICINE, 1999, 246 (06) :599-602

[5] FDA adverse event reports on statin-associated rhabdomyolysis [J].

Omar, MA ;

Wilson, JP .

ANNALS OF PHARMACOTHERAPY, 2002, 36 (02) :288-295

[6] Atorvastatin does not alter the anticoagulant activity of warfarin [J].

Stern, R ;

Abel, R ;

Gibson, GL ;

Besserer, J .

JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (11) :1062-1064

[7] In vitro comparative inhibition profiles of major human drug metabolising cytochrome p450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors [J].

Transon, C ;

Leemann, T ;

Dayer, P .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 50 (03) :209-215

[8] Potential interaction between warfarin and fluvastatin [J].

Trilli, LE ;

Kelley, CL ;

Aspinall, SL ;

Kroner, BA .

ANNALS OF PHARMACOTHERAPY, 1996, 30 (12) :1399-1402

← 1 →